TL;DR
Age-related macular degeneration (AMD) affects millions of people worldwide, representing one of the leading causes of vision loss in adults over 50.
For those grappling with this progressive eye condition, AREDS2 supplements have emerged as a scientifically-backed intervention that offers genuine hope. But do they actually work, and are they right for everyone?
What do AREDS2 supplements aim to treat?
Before examining AREDS2’s effectiveness, it’s essential to understand what we’re treating. Age-related macular degeneration is a progressive condition affecting the macula, the central part of the retina responsible for sharp, detailed vision. This small area enables us to read, drive, recognise faces, and perform tasks requiring fine visual detail.
- Early AMD typically presents with small deposits called drusen under the retina. Many people have no symptoms at this stage, and vision remains largely unaffected.
- Intermediate AMD involves larger drusen and may include pigment changes in the retina. Some people begin experiencing mild vision changes, particularly in low-light conditions.
- Late AMD occurs in two forms: dry (geographic atrophy) and wet (neovascular). Both can result in significant vision loss, affecting central vision whilst typically preserving peripheral vision.
The progression from early to late AMD isn’t inevitable, but understanding where you stand on this spectrum is crucial for determining whether AREDS2 supplements might benefit you.
The scientific foundation: AREDS and AREDS2 studies
The story of AREDS2 supplements begins with groundbreaking research conducted by the National Eye Institute in the United States. The original Age-Related Eye Disease Study (AREDS), published in 2001, was a landmark clinical trial involving 4,757 participants aged 55-80 years over five years.
Original AREDS findings
The AREDS formulation was associated with a 25% reduction to advanced AMD compared with placebo. This represented the first major breakthrough demonstrating that nutritional supplements could slow AMD progression. The original formula contained:
- Vitamin C (500 mg)
- Vitamin E (400 IU)
- Beta-carotene (15 mg)
- Zinc (80 mg as zinc oxide)
- Copper (2 mg as cupric oxide)
However, subsequent research revealed a concerning safety issue: beta carotene supplementation balanced with its possible benefits, which were only demonstrated in exploratory subgroup analysis, substitution with lutein/zeaxanthin in AREDS supplements for beta-carotene may be appropriate. Given the valid safety concerns in current and former smokers.
The AREDS2 evolution
NEI launched AREDS2 in 2006 to test if adding omega-3 fatty acids or lutein + zeaxanthin would make the AREDS formula more effective. This follow-up study enrolled 4,203 participants aged 50-85 years at 82 clinical sites across the United States between 2006 and 2008.
The AREDS2 study had several key objectives:
- Safety improvement: Replace beta-carotene with lutein and zeaxanthin to eliminate lung cancer risk in smokers
- Efficacy enhancement: Test whether omega-3 fatty acids could provide additional protection
- Optimisation: Evaluate whether reducing zinc levels would maintain effectiveness whilst reducing potential side effects
Key AREDS2 findings
The results were both revealing and reassuring. In the AREDS2 trial, adding omega-3 fatty acids or lutein + zeaxanthin to the AREDS formula had no additional overall effect on the risk of advanced AMD. However, AREDS2 participants who took antioxidants minus beta-carotene but with lutein + zeaxanthin (AREDS2 formula) had an incremental increase in benefit, compared to those who took the AREDS formula.
Do AREDS2 supplements actually work?
The evidence supporting AREDS2’s effectiveness is substantial and continues to strengthen with additional research. Here’s what the science tells us:
Proven effectiveness for intermediate and late AMD
AREDS2 included only people with intermediate AMD in both eyes or intermediate AMD in one eye and advanced AMD in the other eye. AREDS2 excluded people without AMD or with early AMD because AREDS data showed no benefit for these individuals.
For the target population – those with intermediate to late AMD – the evidence is compelling. A long-term follow-up study offers the strongest findings to date that reaffirm the optimal eye vitamin supplement formula. This 10-year analysis confirmed that the AREDS2 formula was more effective at reducing the risk of macular degeneration progression compared to the original formula – while also reducing the risk of lung cancer due to beta-carotene.
Breakthrough findings for advanced disease
Recent research has expanded our understanding of AREDS2’s benefits. In July 2024, a significant study published findings that challenged previous assumptions about supplement effectiveness in advanced disease.
New research has found that taking a daily vitamin and mineral supplement can slow the progression of geographic atrophy (GA), an advanced form of dry age-related macular degeneration (AMD). Previously, these supplements, based on the AREDS2 formula, have only been recommended for those with earlier stages of AMD.
The research revealed that widely available AREDS2 supplements, containing vitamins C and E, lutein, zeaxanthin, zinc and copper, could slow down the progression of sight loss in GA patients by 55% over an average of three years.
This finding is particularly significant because geographic atrophy represents the most advanced form of dry AMD, where treatment options have historically been extremely limited.
Long-term safety and efficacy confirmed
A recent report from the second age-related eye disease study (AREDS2) confirms the AREDS2 formulation is safe for use over a decade and is effective in delaying the progression of intermediate to late, sight-threatening age-related macular degeneration (AMD).
This long-term follow-up provides crucial reassurance about sustained benefits and safety over extended periods of use.
Related read: Are AMD Tablets Safe For Long-Term Use?
Who should take AREDS2 supplements?
Understanding who benefits from AREDS2 supplements is crucial for making informed decisions about their use.
Recommended candidates
AREDS2 supplements are specifically recommended for people with:
- Intermediate AMD in both eyes: Those with significant drusen and potential pigment changes
- Intermediate AMD in one eye and advanced AMD in the other: Mixed disease stages requiring intervention
- Advanced dry AMD (geographic atrophy): Based on recent evidence showing progression benefits
Scientists at NEI studied these supplements in 2 clinical trials, called the Age-Related Eye Disease Studies (AREDS and AREDS2). They found that people with intermediate or late AMD who took these supplements every day were less likely to lose their central vision.
Who should NOT take AREDS2 supplements?
- People with early AMD or no AMD: There was no benefit for people with early AMD or for people who do not have AMD
- Those seeking prevention: Nutritional supplements cannot prevent AMD. However, the AREDS/AREDS2 supplements may delay progression of intermediate to advanced AMD and may help you keep your vision longer
Special considerations for smokers
Current and former smokers require particular attention. The original AREDS formula contained beta-carotene, which AREDS2 participants who were former smokers who took a formulation with beta-carotene had a higher incidence of lung cancer.
For this reason, current and former smokers should take the AREDS2 formula and avoid the AREDS formula with beta-carotene, which increases lung cancer risk.
Understanding the ingredients: How AREDS2 works
Each component of the AREDS2 formula serves a specific purpose in protecting macular health:
Lutein and zeaxanthin (12 mg combined)
These macular carotenoids are the star ingredients of AREDS2. They naturally concentrate in the macula, where they:
- Filter harmful blue light before it reaches photoreceptor cells
- Provide antioxidant protection against oxidative damage
- Support macular pigment density, which correlates with better visual function
The replacement of beta-carotene with these carotenoids represented a major safety improvement whilst maintaining effectiveness.
Vitamin C (500 mg)
A potent antioxidant that helps protect retinal cells from oxidative stress. Vitamin C works synergistically with other antioxidants to maintain cellular health.
Related read: What Does Vitamin C Do?
Vitamin E (400 IU)
Another crucial antioxidant that helps protect cell membranes from lipid peroxidation, a process that can damage retinal cells.
Zinc (80 mg) and Copper (2 mg)
Zinc is essential for proper retinal function and is highly concentrated in the eye. The studies showed clear benefits for patients who took an AREDS formula with zinc, with no evidence of anemia. Copper is included to prevent zinc-induced copper deficiency.
Why omega-3s aren’t included
Despite popular belief about omega-3s and eye health, Omega-3 fatty acid supplements do not have an effect on cataract or AMD. The AREDS2 study specifically tested omega-3 fatty acids and found no additional benefit for AMD progression.
Potential side effects and safety considerations
While AREDS2 supplements have an excellent safety profile for most people, it’s important to understand potential side effects and contraindications.
Common side effects
One of the most frequently reported side effects of AREDS2 supplements is gastrointestinal discomfort.
You might experience nausea, indigestion, or an upset stomach, especially if you take the supplement on an empty stomach. Other commonly reported side effects include:
- Digestive issues: AREDS2 supplements can cause changes in your bowel habits, such as diarrhoea or constipation. This is usually temporary, but it can be uncomfortable while it lasts
- Headaches: Some users of AREDS2 supplements report experiencing headaches after taking them. This can be related to certain vitamins, such as vitamin E
Managing side effects
To reduce the chances of experiencing this, it’s advisable to take your supplement with a meal. Most side effects can be minimised by:
- Taking supplements with food
- Starting with a lower dose and gradually increasing
- Ensuring adequate hydration
- Consulting your healthcare provider if side effects persist
Practical guidance for patients
Timing and administration
Most AREDS2 supplements are designed to be taken as two capsules daily, typically one with breakfast and one with dinner. Taking them with food helps reduce gastrointestinal side effects.
Monitoring and follow-up
AREDS2 supplements are not a substitute for regular eye care. Continue with:
- Regular eye examinations as recommended by your eye care professional
- Monitoring for changes in vision
- Discussing any side effects with your healthcare provider
- Maintaining overall eye health through diet and lifestyle
Lifestyle factors that complement AREDS2
AREDS2 supplements work best as part of a comprehensive approach to eye health:
Diet and nutrition
A diet rich in leafy green vegetables naturally provides lutein and zeaxanthin. The Mediterranean diet has shown particular promise, with research suggesting strong dedication to the Mediterranean diet resulted in a 25% reduction in the risk of progressing from early to late macular degeneration, and an almost 30% reduction in the risk of progressing from intermediate to late AMD.
Smoking cessation
Smoking remains the most significant modifiable risk factor for AMD. If you smoke, stopping is the single most important step you can take for your eye health.
UV protection
Protecting your eyes from harmful UV radiation through quality sunglasses may help slow AMD progression.
Regular exercise
Physical activity supports overall vascular health, which benefits the delicate blood vessels in the eye.
The verdict: Do AREDS2 supplements work?
Based on over two decades of rigorous scientific research, the answer is a qualified yes. AREDS2 supplements work effectively for their intended purpose: slowing the progression of intermediate to late AMD.
- Proven effectiveness: A 25% reduction in progression risk for intermediate AMD, with recent evidence suggesting benefits even in advanced disease
- Improved safety: Elimination of lung cancer risk through beta-carotene replacement
- Long-term benefits: Sustained effectiveness over 10+ years of use
- Cost-effectiveness: Economic benefits through delayed progression to expensive-to-treat advanced disease
However, it’s crucial to understand what AREDS2 supplements cannot do:
- They cannot prevent AMD in healthy individuals
- They cannot reverse existing vision loss
- They are not recommended for early AMD
- They don’t provide benefits for everyone
Making an informed decision
For those with intermediate to late AMD, the question isn’t whether AREDS2 supplements work – the evidence clearly shows they do. The question is whether they’re appropriate for your individual circumstances, and that’s a conversation worth having with your eye care team.
The journey with AMD can be challenging, but AREDS2 supplements represent genuine hope backed by solid science. They won’t restore lost vision, but they can help preserve what remains—and for many people, that makes all the difference.
This guide is for educational purposes and should not replace professional medical advice. Always consult with your eye care professional before starting any supplement regimen.
